Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

Cluster analysis to define distinct clinical phenotypes among septic patients with bloodstream infections.

Guilamet MCV, Bernauer M, Micek ST, Kollef MH.

Medicine (Baltimore). 2019 Apr;98(16):e15276. doi: 10.1097/MD.0000000000015276.

2.

Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam, Cefepime, or Meropenem.

Blevins AM, Lashinsky JN, McCammon C, Kollef M, Micek S, Juang P.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e02658-18. doi: 10.1128/AAC.02658-18. Print 2019 May.

PMID:
30782987
3.

Outcomes Associated With De-escalating Therapy for Methicillin-Resistant Staphylococcus aureus in Culture-Negative Nosocomial Pneumonia.

Cowley MC, Ritchie DJ, Hampton N, Kollef MH, Micek ST.

Chest. 2019 Jan;155(1):53-59. doi: 10.1016/j.chest.2018.10.014. Epub 2018 Oct 25.

PMID:
30621854
4.

Duration of Exposure to Antipseudomonal β-Lactam Antibiotics in the Critically Ill and Development of New Resistance.

Teshome BF, Vouri SM, Hampton N, Kollef MH, Micek ST.

Pharmacotherapy. 2019 Mar;39(3):261-270. doi: 10.1002/phar.2201. Epub 2019 Jan 7.

PMID:
30506852
5.

A Hypothesis-Generating Study of the Combination of Aspirin plus Macrolides in Patients with Severe Community-Acquired Pneumonia.

Falcone M, Russo A, Shindo Y, Farcomeni A, Pieralli F, Cangemi R, Liu J, Xia J, Okumura J, Sano M, Jones C, Vannucchi V, Mancone M, Micek S, Xu F, Violi F, Kollef M.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e01556-18. doi: 10.1128/AAC.01556-18. Print 2019 Feb.

PMID:
30509940
6.

Outcomes and Predictors of Early Infection after Heart Transplantation.

Shultes KC, Shuster JE, Micek S, Vader JM, Balsara K, Itoh A, Tellor BR.

Surg Infect (Larchmt). 2018 Jul;19(5):516-522. doi: 10.1089/sur.2017.295. Epub 2018 May 18.

PMID:
29775554
7.

Antidiabetic medication de-escalation following bariatric surgery.

Vouri SM, Chen J, Sparkman J, Salles A, Micek ST.

J Diabetes. 2018 Sep;10(9):768-770. doi: 10.1111/1753-0407.12779. Epub 2018 May 28. No abstract available.

PMID:
29736976
8.

Clinical epidemiology of carbapenem-resistant gram-negative sepsis among hospitalized patients: Shifting burden of disease?

Britt NS, Ritchie DJ, Kollef MH, Burnham CD, Durkin MJ, Hampton NB, Micek ST.

Am J Infect Control. 2018 Oct;46(10):1092-1096. doi: 10.1016/j.ajic.2018.03.013. Epub 2018 Apr 26.

PMID:
29706365
9.

Erratum for Micek et al., "Risk Factors and Outcomes for Ineffective Empiric Treatment of Sepsis Caused by Gram-Negative Pathogens: Stratification by Onset of Infection".

Micek ST, Hampton N, Kollef M.

Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e00007-18. doi: 10.1128/AAC.00007-18. Print 2018 Mar. No abstract available.

10.

Importance of Site of Infection and Antibiotic Selection in the Treatment of Carbapenem-Resistant Pseudomonas aeruginosa Sepsis.

Britt NS, Ritchie DJ, Kollef MH, Burnham CA, Durkin MJ, Hampton NB, Micek ST.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02400-17. doi: 10.1128/AAC.02400-17. Print 2018 Apr.

11.

Sepsis-Associated Coagulopathy Severity Predicts Hospital Mortality.

Lyons PG, Micek ST, Hampton N, Kollef MH.

Crit Care Med. 2018 May;46(5):736-742. doi: 10.1097/CCM.0000000000002997.

PMID:
29373360
12.

The Burden of Viruses in Pneumonia Associated With Acute Respiratory Failure: An Underappreciated Issue.

Shorr AF, Fisher K, Micek ST, Kollef MH.

Chest. 2018 Jul;154(1):84-90. doi: 10.1016/j.chest.2017.12.005. Epub 2017 Dec 21.

PMID:
29274318
13.

Risk Factors and Outcomes for Ineffective Empiric Treatment of Sepsis Caused by Gram-Negative Pathogens: Stratification by Onset of Infection.

Micek ST, Hampton N, Kollef M.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01577-17. doi: 10.1128/AAC.01577-17. Print 2018 Jan. Erratum in: Antimicrob Agents Chemother. 2018 Feb 23;62(3):.

14.

Predicting Resistance to Piperacillin-Tazobactam, Cefepime and Meropenem in Septic Patients With Bloodstream Infection Due to Gram-Negative Bacteria.

Vazquez-Guillamet MC, Vazquez R, Micek ST, Kollef MH.

Clin Infect Dis. 2017 Oct 30;65(10):1607-1614. doi: 10.1093/cid/cix612.

PMID:
29020294
15.

Reply to MacFadden et al.

Vazquez Guillamet MC, Vazquez R, Micek ST, Kollef MH.

Clin Infect Dis. 2018 Jan 18;66(3):479-480. doi: 10.1093/cid/cix776. No abstract available.

PMID:
29020211
16.

Controversies and advances in the management of ventilator associated pneumonia.

Roberts KL, Micek ST, Juang P, Kollef MH.

Expert Rev Respir Med. 2017 Nov;11(11):875-884. doi: 10.1080/17476348.2017.1378574. Epub 2017 Sep 15. Review.

PMID:
28891372
17.

A Prospective One-Year Microbiologic Survey of Combined Pneumonia and Respiratory Failure.

Fisher K, Trupka T, Micek ST, Juang P, Kollef MH.

Surg Infect (Larchmt). 2017 Oct;18(7):827-833. doi: 10.1089/sur.2017.111. Epub 2017 Sep 7.

PMID:
28880805
18.

Enhanced antimicrobial de-escalation for pneumonia in mechanically ventilated patients: a cross-over study.

Trupka T, Fisher K, Micek ST, Juang P, Kollef MH.

Crit Care. 2017 Jul 15;21(1):180. doi: 10.1186/s13054-017-1772-4.

19.

Augmented renal clearance is not a risk factor for mortality in Enterobacteriaceae bloodstream infections treated with appropriate empiric antimicrobials.

Burnham JP, Micek ST, Kollef MH.

PLoS One. 2017 Jul 5;12(7):e0180247. doi: 10.1371/journal.pone.0180247. eCollection 2017.

20.

Recommendations for aerosolized antibiotics in ventilator-associated pneumonia and ventilator-associated tracheobronchitis: too little and too late?

Kollef MH, Micek ST.

Clin Microbiol Infect. 2017 Sep;23(9):593-595. doi: 10.1016/j.cmi.2017.04.001. Epub 2017 Apr 8. No abstract available.

21.

Viruses are prevalent in non-ventilated hospital-acquired pneumonia.

Shorr AF, Zilberberg MD, Micek ST, Kollef MH.

Respir Med. 2017 Jan;122:76-80. doi: 10.1016/j.rmed.2016.11.023. Epub 2016 Nov 29.

22.

Real-time automated clinical deterioration alerts predict thirty-day hospital readmission.

Micek ST, Samant M, Bailey T, Chen Y, Lu C, Heard K, Kollef MH.

J Hosp Med. 2016 Nov;11(11):768-772. doi: 10.1002/jhm.2617. Epub 2016 Jun 3.

23.

A cohort study of bacteremic pneumonia: The importance of antibiotic resistance and appropriate initial therapy?

Guillamet CV, Vazquez R, Noe J, Micek ST, Kollef MH.

Medicine (Baltimore). 2016 Aug;95(35):e4708. doi: 10.1097/MD.0000000000004708.

24.

A Case-Control Study Assessing the Impact of Nonventilated Hospital-Acquired Pneumonia on Patient Outcomes.

Micek ST, Chew B, Hampton N, Kollef MH.

Chest. 2016 Nov;150(5):1008-1014. doi: 10.1016/j.chest.2016.04.009. Epub 2016 Apr 19.

PMID:
27102181
25.

The authors reply.

Kollef MH, Micek ST.

Crit Care Med. 2016 Apr;44(4):e231-2. doi: 10.1097/CCM.0000000000001545. No abstract available.

PMID:
26974455
26.

Editorial Commentary: Antimicrobial De-escalation: What's in a Name?

Kollef MH, Micek ST.

Clin Infect Dis. 2016 Apr 15;62(8):1018-20. doi: 10.1093/cid/civ1201. Epub 2015 Dec 23. No abstract available.

PMID:
26703859
27.

Epidemiology, Co-Infections, and Outcomes of Viral Pneumonia in Adults: An Observational Cohort Study.

Crotty MP, Meyers S, Hampton N, Bledsoe S, Ritchie DJ, Buller RS, Storch GA, Micek ST, Kollef MH.

Medicine (Baltimore). 2015 Dec;94(50):e2332. doi: 10.1097/MD.0000000000002332.

28.

The Importance of Research during Pharmacy Residency Training.

Vouri SM, Stranges PM, Burke JM, Micek S, Pitlick MK, Wenger P.

Curr Pharm Teach Learn. 2015 Nov-Dec;7(6):892-898. Epub 2015 Sep 15.

29.

Impact of antibacterials on subsequent resistance and clinical outcomes in adult patients with viral pneumonia: an opportunity for stewardship.

Crotty MP, Meyers S, Hampton N, Bledsoe S, Ritchie DJ, Buller RS, Storch GA, Kollef MH, Micek ST.

Crit Care. 2015 Nov 18;19:404. doi: 10.1186/s13054-015-1120-5.

30.

Outcomes associated with bacteremia in the setting of methicillin-resistant Staphylococcus aureus pneumonia: a retrospective cohort study.

Shorr AF, Zilberberg MD, Micek ST, Kollef MH.

Crit Care. 2015 Sep 3;19:312. doi: 10.1186/s13054-015-1029-z.

31.

Inadequate Source Control and Inappropriate Antibiotics are Key Determinants of Mortality in Patients with Intra-Abdominal Sepsis and Associated Bacteremia.

Tellor B, Skrupky LP, Symons W, High E, Micek ST, Mazuski JE.

Surg Infect (Larchmt). 2015 Dec;16(6):785-93. doi: 10.1089/sur.2014.166. Epub 2015 Aug 10.

PMID:
26258265
32.

Risk factors for 30-day readmission among patients with culture-positive severe sepsis and septic shock: A retrospective cohort study.

Zilberberg MD, Shorr AF, Micek ST, Kollef MH.

J Hosp Med. 2015 Oct;10(10):678-85. doi: 10.1002/jhm.2420. Epub 2015 Jul 20.

PMID:
26193064
33.

Pseudomonas aeruginosa nosocomial pneumonia: impact of pneumonia classification.

Micek ST, Kollef MH, Torres A, Chen C, Rello J, Chastre J, Antonelli M, Welte T, Clair B, Ostermann H, Calbo E, Wunderink R, Menichetti F, Schramm G, Menon V.

Infect Control Hosp Epidemiol. 2015 Oct;36(10):1190-7. doi: 10.1017/ice.2015.167. Epub 2015 Jul 20.

PMID:
26190444
34.

Time to Appropriate Antibiotic Therapy Is an Independent Determinant of Postinfection ICU and Hospital Lengths of Stay in Patients With Sepsis.

Zhang D, Micek ST, Kollef MH.

Crit Care Med. 2015 Oct;43(10):2133-40. doi: 10.1097/CCM.0000000000001140.

PMID:
26121071
35.

An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance.

Micek ST, Wunderink RG, Kollef MH, Chen C, Rello J, Chastre J, Antonelli M, Welte T, Clair B, Ostermann H, Calbo E, Torres A, Menichetti F, Schramm GE, Menon V.

Crit Care. 2015 May 6;19:219. doi: 10.1186/s13054-015-0926-5.

36.

Clinical effectiveness of a sedation protocol minimizing benzodiazepine infusions and favoring early dexmedetomidine: a before-after study.

Skrupky LP, Drewry AM, Wessman B, Field RR, Fagley RE, Varghese L, Lieu A, Olatunde J, Micek ST, Kollef MH, Boyle WA.

Crit Care. 2015 Apr 2;19:136. doi: 10.1186/s13054-015-0874-0.

37.

Surveillance versus clinical adjudication: differences persist with new ventilator-associated event definition.

McMullen KM, Boyer AF, Schoenberg N, Babcock HM, Micek ST, Kollef MH.

Am J Infect Control. 2015 Jun;43(6):589-91. doi: 10.1016/j.ajic.2015.03.004. Epub 2015 Apr 3.

PMID:
25845723
38.

Development and validation of a clinical prediction rule for candidemia in hospitalized patients with severe sepsis and septic shock.

Guillamet CV, Vazquez R, Micek ST, Ursu O, Kollef M.

J Crit Care. 2015 Aug;30(4):715-20. doi: 10.1016/j.jcrc.2015.03.010. Epub 2015 Mar 14.

PMID:
25813550
39.

Clostridium difficile recurrence is a strong predictor of 30-day rehospitalization among patients in intensive care.

Zilberberg MD, Shorr AF, Micek ST, Kollef MH.

Infect Control Hosp Epidemiol. 2015 Mar;36(3):273-9. doi: 10.1017/ice.2014.47.

PMID:
25695168
40.

Pneumonia Pathogen Characterization Is an Independent Determinant of Hospital Readmission.

Andruska A, Micek ST, Shindo Y, Hampton N, Colona B, McCormick S, Kollef MH.

Chest. 2015 Jul;148(1):103-111. doi: 10.1378/chest.14-2129.

PMID:
25429607
41.

Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study.

Zilberberg MD, Shorr AF, Micek ST, Vazquez-Guillamet C, Kollef MH.

Crit Care. 2014 Nov 21;18(6):596. doi: 10.1186/s13054-014-0596-8.

42.

Predictors of hospital mortality among septic ICU patients with Acinetobacter spp. bacteremia: a cohort study.

Shorr AF, Zilberberg MD, Micek ST, Kollef MH.

BMC Infect Dis. 2014 Oct 30;14:572. doi: 10.1186/s12879-014-0572-6.

43.

Rational use of antibiotics in the ICU: balancing stewardship and clinical outcomes.

Kollef MH, Micek ST.

JAMA. 2014 Oct 8;312(14):1403-1404. doi: 10.1001/jama.2014.8427. No abstract available. Erratum in: JAMA. 2017 Apr 18;317(15):1584.

PMID:
25271415
44.

Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock.

Vazquez-Guillamet C, Scolari M, Zilberberg MD, Shorr AF, Micek ST, Kollef M.

Crit Care Med. 2014 Nov;42(11):2342-9. doi: 10.1097/CCM.0000000000000516.

PMID:
25072764
45.

Effects of empiric antifungal therapy for septic shock on time to appropriate therapy for Candida infection: a pilot study.

Micek ST, Arnold H, Juang P, Hampton N, McKenzie M, Scolarici M, Kollef M.

Clin Ther. 2014 Sep 1;36(9):1226-32. doi: 10.1016/j.clinthera.2014.06.028. Epub 2014 Jul 23.

PMID:
25064625
46.

Innovation in clinical pharmacy practice and opportunities for academic--practice partnership.

Gubbins PO, Micek ST, Badowski M, Cheng J, Gallagher J, Johnson SG, Karnes JH, Lyons K, Moore KG, Strnad K.

Pharmacotherapy. 2014 May;34(5):e45-54.

PMID:
24877189
47.

A prospective evaluation of ventilator-associated conditions and infection-related ventilator-associated conditions.

Boyer AF, Schoenberg N, Babcock H, McMullen KM, Micek ST, Kollef MH.

Chest. 2015 Jan;147(1):68-81. doi: 10.1378/chest.14-0544.

PMID:
24854003
48.

Macrolides are associated with a better survival rate in patients hospitalized with community-acquired but not healthcare-associated pneumonia.

McEvoy C, Micek ST, Reichley RM, Kan J, Hoban A, Hoffmann J, Shorr AF, Kollef MH.

Surg Infect (Larchmt). 2014 Jun;15(3):283-9. doi: 10.1089/sur.2013.076. Epub 2014 May 6.

PMID:
24801126
49.

Identifying critically ill patients at risk for inappropriate antibiotic therapy: a pilot study of a point-of-care decision support alert.

Micek ST, Heard KM, Gowan M, Kollef MH.

Crit Care Med. 2014 Aug;42(8):1832-8. doi: 10.1097/CCM.0000000000000337.

PMID:
24751497
50.

A randomized trial of real-time automated clinical deterioration alerts sent to a rapid response team.

Kollef MH, Chen Y, Heard K, LaRossa GN, Lu C, Martin NR, Martin N, Micek ST, Bailey T.

J Hosp Med. 2014 Jul;9(7):424-9. doi: 10.1002/jhm.2193. Epub 2014 Apr 7.

Supplemental Content

Support Center